# KLEB, Inc – FDA Inspection, Sep 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/kleb-inc/8ca4207e-8f6b-419c-8926-0fdf994c05d1
Source feed: FDA_Inspections

> FDA inspection 1335600 of KLEB, Inc, September 14, 2026. 1 citation under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1335600
- Company Name: KLEB, Inc
- Inspection Date: 2026-09-14
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Cincinnati District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1163378 - 2022-02-23
- FDA Inspection 1076519 - 2018-12-19
- FDA Inspection 993737 - 2016-12-08
- FDA Inspection 902025 - 2014-10-30
- FDA Inspection 806766 - 2012-11-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/kleb-inc/430029a6-70a0-4628-a57a-e67b8e437351

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22